We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+5.86%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$3.39B
AUM Growth
-$3.22M
(-0.09%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
13.53%
Holding
1,471
New
480
Increased
247
Reduced
250
Closed
489
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$46.4M |
| 2 |
Starbucks
SBUX
|
+$45M |
| 3 |
Boeing
BA
|
+$43.3M |
| 4 |
Medtronic
MDT
|
+$37.9M |
| 5 |
Pfizer
PFE
|
+$37.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$54.8M |
| 2 |
Wells Fargo
WFC
|
+$37.8M |
| 3 |
Caterpillar
CAT
|
+$37.8M |
| 4 |
Union Pacific
UNP
|
+$36.6M |
| 5 |
MetLife
MET
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.36% |
| 2 | Healthcare | 12% |
| 3 | Industrials | 11.97% |
| 4 | Technology | 9.55% |
| 5 | Consumer Staples | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
801
DELISTED
Genomic Health, Inc.
GHDX
| $281K | 0.01% |
+9,614
| New | +$305K |
|
802
Powell Industries
POWL
$7.32B
| $280K | 0.01% |
+12,525
| New | +$270K |
|
803
BCE
BCE
$20.3B
| $279K | 0.01% |
+6,448
| New | +$280K |
|
|
PPLI
804
People Inc
PPLI
$3.13B
| $279K | 0.01% |
+22,706
| New | +$234K |
|
|
ELGX
805
DELISTED
Endologix Inc
ELGX
| $279K | 0.01% |
1,599
+443
| +38% | +$76.1K |
|
806
Kosmos Energy
KOS
$1.39B
| $277K | 0.01% |
24,784
-20,065
| -45% | -$215K |
|
|
MSCC
807
DELISTED
Microsemi Corp
MSCC
| $276K | 0.01% |
11,070
-31,447
| -74% | -$763K |
|
|
AMSG
808
DELISTED
Amsurg Corp
AMSG
| $276K | 0.01% |
6,019
+394
| +7% | +$17.4K |
|
809
NorthWestern Energy
NWE
$4.45B
| $275K | 0.01% |
+6,359
| New | +$284K |
|
810
The Ensign Group
ENSG
$10.7B
| $274K | 0.01% |
+24,223
| New | +$268K |
|
811
Robert Half
RHI
$4.04B
| $274K | 0.01% |
+6,517
| New | +$257K |
|
812
Sasol
SSL
$7.03B
| $274K | 0.01% |
+5,531
| New | +$274K |
|
|
SYKE
813
DELISTED
SYKES Enterprises Inc
SYKE
| $272K | 0.01% |
+12,482
| New | +$250K |
|
814
Barclays
BCS
$91B
| $270K | 0.01% |
16,074
-79,568
| -83% | -$1.26M |
|
815
Integra LifeSciences
IART
$1.54B
| $268K | 0.01% |
+13,749
| New | +$252K |
|
816
Modine Manufacturing
MOD
$11B
| $268K | 0.01% |
+20,916
| New | +$280K |
|
817
Greif
GEF
$4.74B
| $267K | 0.01% |
5,095
-8,670
| -63% | -$455K |
|
|
TNGO
818
DELISTED
Tangoe, Inc.
TNGO
| $266K | 0.01% |
+14,750
| New | +$280K |
|
|
MOVE
819
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $266K | 0.01% |
+16,625
| New | +$271K |
|
820
Take-Two Interactive
TTWO
$46.3B
| $265K | 0.01% |
+15,252
| New | +$264K |
|
|
TFCF
821
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $265K | 0.01% |
+7,666
| New | +$256K |
|
822
SPX Corp
SPXC
$10.2B
| $264K | 0.01% |
10,527
+79
| +0.8% | +$1.82K |
|
|
IPXL
823
DELISTED
Impax Laboratories, Inc.
IPXL
| $263K | 0.01% |
10,446
-6,297
| -38% | -$140K |
|
824
Clearwater Paper
CLW
$282M
| $262K | 0.01% |
4,997
-3,851
| -44% | -$197K |
|
|
INFN
825
DELISTED
Infinera Corporation Common Stock
INFN
| $262K | 0.01% |
+26,809
| New | +$266K |
|
Similar funds
CCA
GAMA
TWP
ACA
CAAM
RK
PCM
ITC
Stevens Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Stevens Capital Management held 1,471 positions worth $3.39B, down 0.09% from $3.39B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Stevens Capital Management withdrew a net $121M in Q4 2013, closing 489 positions and reducing 250 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $54.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in PepsiCo worth $46.3M.
- Stevens Capital Management's largest Q4 2013 buy was PepsiCo: 558,634 shares worth $46.3M.
- Stevens Capital Management added most to Pfizer in Q4 2013, an estimated $37.5M increase.
- Stevens Capital Management's biggest Q4 2013 reduction was Wells Fargo, cutting an estimated $37.8M.
- Stevens Capital Management fully exited Alphabet (Google) Class C in Q4 2013, selling an estimated $54.8M.
- Stevens Capital Management's ten largest holdings make up 14% of its $3.39B portfolio in Q4 2013.
- Stevens Capital Management opened 480 new positions and closed 489 in Q4 2013.
- Stevens Capital Management's portfolio value fell 0.09% quarter-over-quarter to $3.39B.
Based on Stevens Capital Management's 13F filing for Q4 2013, filed 6 Feb 2014.